Medicine Distribution in Ethiopia's Regions: How Medicines Reach Beyond Addis Ababa
Medicine distribution in Ethiopia's regions: how EPSS hubs and private wholesalers reach regional facilities, and what to ask a distributor about coverage.
Yes, medicines reach customers outside Addis Ababa, but through two different routes. Public facilities are supplied by the Ethiopian Pharmaceuticals Supply Service (EPSS), which lists more than 4,000 health facilities across all regions, while private pharmacies and hospitals buy from licensed wholesalers and importers. Medicine distribution in Ethiopia's regions is therefore only as strong as the specific hub, vehicle and wholesaler behind each delivery, and a manufacturer should ask a distributor to name them.
How medicine distribution in Ethiopia's regions works
Medicines enter Ethiopia through licensed importers, and EPSS has its head office in Addis Ababa. Our note on medical supplies in Addis Ababa covers that capital-city market. Beyond it, the flow splits. Public hospitals, health centres and health posts draw stock from EPSS. Private outlets draw from wholesalers. Under EFDA's import and distribution rules, a licensed supplier may distribute only to institutions authorised for that level of trade, so a regional route has to stay inside the licence chain at every step. The importer versus wholesaler guide explains the licence tiers.
The public route: EPSS hubs and the last mile
EPSS says it connects more than 4,000 health facilities serving over 50 million people, with a reported 99 percent on-time delivery rate and GPS tracking (EPSS website, 2026). A more detailed breakdown appeared in Capital Ethiopia on 31 August 2026: EPSS supplies more than 420 hospitals, 4,100 health centres and 18,500 health posts. It has moved away from routing stock through intermediate district hubs and now makes direct deliveries to facilities, which the article puts at approximately 77 percent of distributions. The same article says the full cycle to get a commodity to a remote health post fell from as long as 400 days to under 115 days.
EPSS does not publish a national hub count that we could find, so we will not give one. Regional studies show the shape. A 2025 study in Frontiers in Public Health found that public facilities in the Amhara region were primarily supplied through four EPSS hubs, three of them named as Bahir Dar, Addis Ababa and Gondar, with the remainder served through woreda health offices (Mekonen, Cho and Fenta, 24 March 2025). In another regional account, EPSS's Hawassa office, one of 19 EPSS branches, delivered to 439 health facilities, and EPSS delivered to 70 percent of the 1,225 health centres that report stock digitally while the rest depended on woredas (The Reporter Ethiopia, 23 March 2024).
For a manufacturer the point is that "supplied by EPSS" covers very different last-mile arrangements. Medicines may arrive by EPSS vehicle, by woreda collection, or through a hub in another city. Temperature-sensitive lines make this matter more; see our guide to the pharmaceutical cold chain in Ethiopia.

What the sources say about roads and security
We limit this section to what named sources report, with dates, because conditions change and unverified claims about specific regions help nobody. In March 2024, The Reporter described security problems in conflict-prone areas around Hawassa: some deliveries needed police or woreda escorts, vehicles had been commandeered or destroyed, and in at least one woreda EPSS did not enter at all, with officials collecting supplies at a rendezvous point instead (The Reporter Ethiopia, 23 March 2024). The same article carried a disputed point: EPSS staff said woredas lacked cold-chain equipment, while the Sidama Health Bureau said every woreda has refrigerators that hold temperature for up to three days without power.
Those accounts are more than two years old and cover one part of the country. They show that reach on paper and reach on the ground can differ, which is the reason to ask a distributor for route-level answers rather than a list of regions.
Availability data points the same way. A survey of non-communicable disease medicines in Arba Minch found 16.3 percent availability in public facilities against 38.3 percent in private ones (survey of March to May 2023). Nationally, pooled public availability was 64 percent (systematic review, 2025). Our post on essential medicine availability goes through those figures.
The private route: wholesalers and regional pharmacies
We searched for a primary or peer-reviewed source describing how private wholesalers in regional cities buy from Addis Ababa importers and found none, so we will not describe it as if it were documented. What the record does show is the number of licensed players: 133 importers, 272 wholesalers, 377 pharmacies, 1,699 drug shops and 1,392 rural drug vendors in EFMHACA data cited in 2025 (Mekasha et al., 12 March 2025; the figures are undated and trace to 2013). The retail tiers outnumber importers many times over, which suggests that importers depend on wholesalers to reach them, though we could not find a source that measures it.
For a manufacturer, that means regional coverage is partly a function of who the importer's wholesaler customers are, where they trade, and whether they are licensed. The EFDA register at eRIS lists registered wholesalers, so a claim of "200 wholesalers" can be spot-checked; our guide on verifying a medicine supplier shows how.
What a manufacturer should ask about regional coverage
- Named places. Which regions and cities do your own staff visit, and which are served only through wholesalers?
- Field staff. How many medical representatives work outside Addis Ababa, and who employs them? See medical representatives in Ethiopia.
- Wholesaler customers. How many are in regional cities, and can the distributor name a few?
- Public deliveries. If you win a tender, who moves the goods to EPSS hubs, and what happens when a hub is hard to reach?
- Storage and temperature. What does a delivery to a regional city look like for a refrigerated product? Our good distribution practice post sets out the checks.
- Disruption. How does the distributor handle a route that is closed or unsafe for a period?
LifeCare's answer on regional reach
LifeCare has more than 20 medical representatives working in Addis Ababa and in different regions of Ethiopia, and it serves more than 200 pharmaceutical wholesalers, as well as EPSS, the Federal Ministry of Health, private hospital chains and NGO procurement. Its Top-20 Supplier standing with EPSS from 2022 to 2025 is a record of delivering to the public system. Ask us for the named regions, towns and routes, the same questions as in the list above, and hold us to them. For what LifeCare stocks, see the pharmaceuticals range and the distributor product range post.
Frequently asked questions
How do medicines reach regional hospitals in Ethiopia?
Public hospitals are supplied by EPSS, which reports serving more than 4,000 health facilities across all regions. Stock comes through EPSS hubs and, for some facilities, through woreda health offices. Private hospitals buy from licensed importers and wholesalers.
How many EPSS hubs are there?
We found no published national count. A 2025 study found four hubs supplying public facilities in the Amhara region alone, and a 2024 report described Hawassa as one of 19 EPSS branches.
Do private pharmacies outside Addis Ababa buy from importers directly?
No source we could open describes this flow. The licence data shows far more pharmacies and drug shops than importers, so wholesalers are likely the main link, but a distributor should confirm it for its own customers.
Is it safe to move medicines to every region?
Not uniformly. In 2024 a national outlet reported that some deliveries in conflict-prone areas needed security escorts. A responsible distributor can tell you which routes it serves, how, and with what interruptions.
What should a manufacturer check before signing a regional distribution deal?
Ask for named regions, field staff numbers, wholesaler customers in those regions, and the cold-chain method for sensitive products. Then spot-check the licences on the EFDA register.
If you are a manufacturer comparing partners, our partners page explains how to start.